Andrew Henderson

Dr. Andrew Henderson’s practice focuses on domestic and international patent drafting and prosecution in the fields of biochemistry, molecular biology, immunology, biotechnology, genomics, antibodies, drug discovery, diagnostics, oncology and cancer therapeutics.

Prior to joining Cooley, Andrew was a graduate student at the University of Michigan where his doctoral research in chemical biology focused on defining protein-protein interactions involved in human gene expression and discovering novel small-molecule inhibitors of those challenging protein surfaces. Before graduate school Andrew worked at Dendreon, a cancer immunotherapy company, in Seattle where he worked in operations and logistics.